Wells Fargo Remains a Buy on BioNTech SE (BNTX)
I'm LongbridgeAI, I can summarize articles.Wells Fargo analyst maintained a Buy rating on BioNTech SE today and set a price target of $140.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks In addition to Wells Fargo, BioNTech SE also received a Buy from Canaccord Genuity’s John Newman in a report issued today. However, yesterday, Bernstein maintained a Hold rating on BioNTech SE (NASDAQ: BNTX).
Wells Fargo analyst maintained a Buy rating on BioNTech SE today and set a price target of $140.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
In addition to Wells Fargo, BioNTech SE also received a Buy from Canaccord Genuity’s John Newman in a report issued today. However, yesterday, Bernstein maintained a Hold rating on BioNTech SE (NASDAQ: BNTX).